18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease

Digestive Diseases and Sciences

Volumn 57, Issue 10, 2012, Pages 2658-2668

  Holtmann, Martin H ^a   Uenzen, Manuela ^a   Helisch, Andreas ^a   Dahmen, Anja ^a   Mudter, Jonas ^b   Goetz, Martin ^a   Schreckenberger, Mathias ^a   Galle, Peter R ^a   Bartenstein, Peter ^a,c   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Colonoscopy; Crohn's disease; MRI; Non invasive PET

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; ENDOSCOPY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STENOSIS; EVALUATION; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING;

ADULT; COLONOSCOPY; CROHN DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84867859575     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2190-8     Document Type: Article

References (35)

1. Fireman Z, Mahajna E, Broide E, et al. Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut. 2003; 52:390-392.
2. Voderholzer WA, Beinhoelzl J, Rogalla P, et al. Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut. 2005;54:369-373.
3. Voderholzer WA, Ortner M, Rogalla P, Beinholzl J, Lochs H. Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis. Endoscopy. 2003;35: 1009-1014.
4. Sinha R, Murphy P, Hawker P, Sanders S, Rajesh A, Verma R. Role of MRI in Crohn's disease. Clin Radiol. 2009;64:341-352.
5. Schunk K, Kern A, Heussel CP, et al. Assessment of inflammatory activity in Crohn disease with hydro-MRI. Rofo. 2000;172: 153-160.
6. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut. 2009;58:1113-1120.
7. Rieber A, Wruk D, Nussle K, et al. MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA. Radiologe. 1998;38:23-28.
8. Albert JG, Martiny F, Krummenerl A, et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut. 2005;54:1721-1727.
9. Horsthuis K, Lavini Mphil C, Stoker J. MRI in Crohn's disease. J Magn Reson Imaging. 2005;22:1-12.
10. Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut. 2005;54: 250-256.
11. Lee JK, Marcos HB, Semelka RC. MR imaging of the small bowel using the HASTE sequence. AJR Am J Roentgenol. 1998;170:1457-1463.
12. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in smallbowel Crohn's disease. AJR Am J Roentgenol. 2009;193:113-121.
13. Kubota K. From tumor biology to clinical Pet: a review of positron- emission tomography (PET) in oncology. Ann Nucl Med. 2001;15:471-486.
14. Kumar R, Alavi A. Clinical applications of fluorodeoxyglucose- positron-emission tomography in the management of malignant melanoma. Curr Opin Oncol. 2005;17:154-159.
15. Hellwig D, Baum RP, Kirsch C. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: A systematic review. Nuklearmedizin. 2009;48:59-69. (quiz N8-9).
16. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences Gastroenterology 2004;126:1504-1517
17. de Geus-Oei LF, Vriens D, van Laarhoven HW, van der Graaf WT, Oyen WJ. Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med. 2009;50:43S-54S.
18. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3-15.
19. Bartenstein P, Weindl A, Spiegel S, et al. Central motor processing in Huntington's disease. A PET study. Brain. 1997;120: 1553-1567.
20. El-Haddad G, Zhuang H, Gupta N, Alavi A. Evolving role of positron-emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34:313-329.
21. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18F-fluoro-D-deoxyglucose positron-emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis. 2002;21:247-257.
22. Lemberg DA, Issenman RM, Cawdron R, et al. Positron-emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:733-738.
23. Louis E, Ancion G, Colard A, Spote V, Belaiche J, Hustinx R. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med. 2007;48:1053-1059.
24. Meisner RS, Spier BJ, Einarsson S, et al. Pilot study using PET/ CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13: 993-1000.
25. Rubin DT, Surma BL, Gavzy SJ, et al. Positron-emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Inflamm Bowel Dis. 2009;15:750-755.
26. Neurath MF, Vehling D, Schunk K, et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron-emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97:1978-1985.
27. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
28. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30:983-989.
29. Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol. 2010;12:85-88.
30. Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol. 2009;12: 85-88.
31. Jacene HA, Ginsburg P, Kwon J, et al. Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT. J Nucl Med. 2009;50:1751-1759.
32. Monteleone I, Pallone F, Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm. 2009;2009:297645.
33. Rovedatti L, Kudo T, Biancheri P, et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut. 2009;58:1629-1636.
34. Neurath MF, Finotto S. Translating inflammatory bowel disease research into clinical medicine. Immunity. 2009;31:357-361.
35. Ferrante M, D'Haens G, Rutgeerts P, Vermeire S, Van Assche G. Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease). Curr Gastroenterol Rep. 2009;11:504-508.